- Sponsored Content
- Single Use
Enhancing Cell Viability Through Controlled Freezing
Brian Moloney
March 28, 2024
1 Min Read
Sponsored by Single Use Support
Cell viability is the cornerstone of successful outcomes in biotechnology research and therapeutic applications. However, freezing cells, particularly in advanced therapy or vaccine manufacturing, poses significant challenges in maintaining viability after thawing. Freezing rates and specific additives must be understood and controlled so that sensitive cells are not damaged. To identify the optimal freezing rate for maximum cell viability, Single Use Support conducted a comprehensive study using its controlled rate cryogenic freezer to freeze Chinese hamster ovary (CHO-K1) cells.
Fill out the form below to read the full report.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More
